Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel

Cancer Chemotherapy and Pharmacology

Volumn 43, Issue 2, 1999, Pages 165-172

  Schimming, Ronald ^a   Mason, Kathryn A ^a   Hunter, Nancy ^a   Weil, Michael ^a   Kishi, Kazushi ^a   Milas, Luka ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Cell lysis; Docetaxel; Mitotic arrest; Mouse tumors; p53

Indexed keywords

DOCETAXEL; PACLITAXEL; PROTEIN P53; RNA;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFICACY; GENE MUTATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; SQUAMOUS CELL CARCINOMA; TUMOR CELL DESTRUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; GENES, P53; MICE; MICE, INBRED STRAINS; MITOSIS; MUTATION; NEOPLASMS, EXPERIMENTAL; PACLITAXEL; SPECIFIC PATHOGEN-FREE ORGANISMS; TAXOIDS;

EID: 0032930827     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050879     Document Type: Article

References (56)

1. Bhalla K, Ilerado AM, Tourkina E, Tang C, Mahoney ME, Huang Y (1993) Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7: 563
2. Bissery M, Nohynek G, Sanderink GJ, Lavelle F (1995) Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience. Anticancer Drugs 6: 339
3. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM (1996) Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-Raf-1 signal transduction pathway. Cancer Res 56: 1851
4. Bogden C, Ding A (1992) Taxol, a microtubule stabilizing antineoplastic agent, induces expression of tumor necrosis-α and interleukin-1 in macrophages. J Leukoc Biol 52: 119
5. Burkhart C, Berman J, Swindell CS, Horwitz SB (1994) Relationship between the structure of taxol and other taxanes of induction of tumor necrosis, gene expression and cytotoxicity. Cancer Res 54: 5779
6. Catimel G, Verweij J, Mattijssen V (1994) Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. Ann Oncol 5: 533
7. Chevallier B, Fumoleau P, V Kerbrat P, Dieras V, Roche H, Krakowski I, Azli N, Bayssas M, Leutz M, Van Glabbeke M (1995) Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a Phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol 13: 314
8. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156
9. Cortex J, Pazdur R (1995) Docetaxel. J Clin Oncol 13: 2643
10. Debernardis, D, Graniela S, De Feudis E, Vikhanskaya P, Valenti F, Russo M, Parodi P, D'Incalci S, Broggini M (1997) p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res 57: 870
11. Ding A, Porteu F, Sanchez E, Nathan CF (1990) Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248: 370
12. Dreyfuss A, Clark JR, Norris CM, Rossi RM, Lucarini JW, Busse PM, Poulin MD, Thornihill L, Costello R, Posner MR (1996) Docetaxel (Taxotere): an active drug against squamous cell carcinoma of the head and neck. J Clin Oncol 14: 1672
13. Dustin P (1980) Microtubules. Sci Am 243: 66
14. Elomaa L, Joensuu H, Kulmala J, Klemi P, Grenman R (1995) Squamous cell carcinoma is highly sensitive to Taxol, a possible new radiation sensitizer. Acta Otolaryngol 115: 340
15. Fossella F, Lee J, Murphy WK, Lippman SM, Calayag M, Pang A, Chosen M, Shin DM, Glisson B, Benner S, Huber M, Perez-Soler R, Hong WK, Raber M (1994) Phase II study of docetaxel for recurrent or metastatic non-small lung cancer. J Clin Oncol 12: 1238
16. Fossella F, Lee JS, Shin DM (1995) Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small cell lung cancer. J Clin Oncol 13: 645
17. Francis PA, Rigas JR, Kris MG, Pisters KM, Orazem JP, Woolley KJ, Heelan RT (1994) Phase II docetaxel in patients with stage III and IV non-small cell lung cancer. J Clin Oncol 12: 1232
18. Gangemi RMR, Tiso M, Marchetti C, Severi AB, Fabbi M (1995) Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother Pharmacol 36: 385
19. Haldar S, Jena N, Croce CM (1995) Inactivation of bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92: 4507
20. Haldar S, Chintapalli J, Croce CM (1996) Taxol-induced bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253
21. Haldar S, Basu A, Croce CM (1997) Bcl-2 is the guardian of microtubule integrity. Cancer Res 57: 229
22. Hanauske A, Degen D, Hilsenbeck SG, Bissery MC, Von Hoff DD (1992) Effects of taxotere and taxol on in vivo colony formation of freshly explanted human tumor cells. Anticancer Drugs 3: 121
23. Hudis CA, Seidman AD, Crown JP, Balmaceda C, Freilich R, Gilewski TA, Hakes TB, Currie V, Lebwohl DE, Baselga J, Raptis G, Gollub M, Robles M, Bruno R, Norton L (1996) Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer. J Clin Oncol 14: 58
24. Jordon MA, Wendell K, Gardiner S. Derry WB, Copp H, Wilson L (1996) Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56: 1253
25. Kastan MB, Canman CE, Leonard CJ (1995) P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14: 3
26. Korsmeyer SJ (1992) Bcl-2: a repressor of lymphocyte death. Immunol Today 13: 285
27. Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, Andre S (1995) Preclinical evaluation of Docetaxel (Taxotere). Semin Oncol 22(2): 3
28. Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957
29. Manthey CL, Qureshi N, Stutz PL, Vogel SN (1993) Lipopolysaccharide antagonists block taxol-induced signalling in murine macrophages. J Exp Med 178: 695
30. Mason KA, Milas L, Peters LJ (1995) Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa. Int J Radiat Oncol Biol Phys 32: 11381
31. Mason K, Hunter N, Milas M, Abbruzzese JL, Milas L (1997) Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res 3: 2431
32. Meyn RE, Stephens LC, Hunter NR, Milas L (1995) Apoptosis in murine tumors treated with chemotherapy agents. Anticancer Drugs 6: 443
33. Milas L, Hunter N, Mason KA, Withers HR (1974) Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different size. Cancer Res 34: 61
34. Milas L, Hunter N, Basic I, Mason K, Grdina DJ, Withers HR (1975) Nonspecific immunotherapy of murine solid tumors with Corynebacterium granulosum. J Natl Cancer Inst 54: 895
35. Milas L, Wike J, Hunter N, Volpe J, Basic I (1987) Macrophage content of murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. Cancer Res 47: 1069
36. Milas L, Hunter N, Mason KA, Milross CG, Satio Y, Peters LJ (1995) Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 55: 3564
37. Milas L, Hunter NR, Kurdoglu B, Mason KA, Meyn RE, Stephens LC, Peters LJ (1995) Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol 35: 297
38. Milas L, Saito Y, Hunter NR, Milross CG, Mason KA (1996) Therapeutic potential of paclitaxel radiation treatment of a murine ovarian carcinoma. Radiother Oncol 40: 163
39. Milross CG, Peters LJ, Hunter NR, Mason KA, Milas L (1996) Sequence-dependent antitumor activity of paclitaxel (Taxol) and cisplatin in vivo. Int J cancer 62: 599
40. Milross GC, Mason KA, Hunter NR, Chung WK, Peteres LJ, Milas L (1996) Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 88: 1308
41. Milross C, Mason K, Hunter NR, Terry NHA, Patel N, Harada, S, Jibu T, Seong J, Milas L (1997) Enhanced radioresponse of paclitaxel-sensitive and -resistant tumors in vivo. Eur J Cancer 33: 1299
42. Provinciali M, Stefano DI, Ciavanttini A, Garzetti GG (1997) Baseline apoptosis of tumor cells as a response predictor to chemotherapy. J Natl Cancer Inst 89: 889
43. Ringel I, Horwitz S (1991) Studies with RP 56976 (Taxotere): a semisynthetic analogue of Taxol. J Natl Cancer Inst 83: 288
44. Rowinsky E (1997) The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48: 353
45. Saito Y, Milross C, Hittelman WN, Li D, Jibu T, Peters LJ, Milas L (1997) Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resisitant to apoptosis induction. Int J Radiat Oncol Biol Phys 38: 623
46. Schiff P, Fant S, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277: 665
47. Scott MT, Milas L (1977) The distribution and persistance in vivo of Corynebacterium parvum in relation to its antitumor activity. Cancer Res 37: 1673
48. 2/M phase. Oncol Rep 4: 1151
49. Tishler RB, Lampus DM, Park S, Price BD (1995) Microtubule-active drugs taxol, vinblastine, and nocodazole increase the level of transcriptionally active p53. Cancer Res 55: 6021
50. Trudeau ME, Eisenhauer EA, Higgins BP, Letendre F, Lofters WS, Noriss BD, Vandenberg TA, Delorme F, Muldal AM (1996) Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14: 422
51. Van Oosterom A, Schrijvers D (1995) Docetaxel (Taxotere), a review of preclinical and clinical experience: Part II: Clinical experience. Anticancer Drugs 6: 356
52. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW, Galloway DA (1996) Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 2: 72
53. Wani M, Taylor HL, Wall ME, Coggan P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, anovel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325
54. Woods CM, Zhu J, Mcqueney PA, Bollag D, Lazarides E (1995) Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med 1: 506
55. Wyllie AH (1992) Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 11: 95
56. Zar J (1984) Biostatistical analysis. Prentice-Hall, Englewood Cliffs